Roivant's experimental lung disease drug meets goals in mid-stage study
- Posted on September 9, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Roivant's experimental lung disease drug meets goals in mid-stage study
By Sahil Pandey Sept 8 (Reuters) - Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients with high blood pressure associated with a type of lung disease, sending shares up about 17%. Roivant has been expanding its late-stage pipeline after winning U.S. approval last month for skin and muscle disease treatment Lisraya. • The drug developer said its
